Veterinary Vaccines Market worth $7,197.9 Million by 2020

The report “Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles), Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020”, provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global market along with estimates and forecast of revenue.

Browse 124 market data tables and 65 figures spread through 250 pages and in-depth TOC on “Veterinary / Animal Vaccines Market"

http://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.html

Early buyers will receive 10% customization on this report.

The global veterinary vaccines market is poised to reach $7,197.9 Million by 2020 from $5507.3 Million in 2015, at a CAGR of 5.5% from 2015 to 2020.

Factors such as growing prevalence of animal diseases, increasing incidences of zoonotic diseases, rising investments by government bodies and associations, and launches of innovative products by companies are driving the veterinary vaccines market. However, rising costs of storage and maintenance of vaccines, increasing adoption of vegetarian food in major economies owing to increasing risk of obesity and other chronic disorders, and persistent economic slowdown are major factors hindering the growth of veterinary vaccines market.

Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1233

The market is segmented on the basis of products, diseases, technologies and regions. The veterinary vaccine products market is categorized into companion animal vaccines, livestock, poultry, porcine, equine, aquaculture, and other animal vaccines. In this market, the companion animal vaccines segment is the fastest-growing segment due to increasing awareness about vaccination, rising incidence of zoonotic diseases in humans, and increasing pet population.

On the basis of technology, the veterinary vaccines market is classified into inactivated vaccines, live attenuated vaccines, toxoid vaccines, conjugate vaccines, DNA vaccines, recombinant vaccines, subunit vaccines.  Live attenuated vaccine technology is the major technology in the veterinary vaccines market.

On the basis of region, the veterinary vaccines market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2014, Europe accounted for the largest share of the veterinary vaccines market, followed by North America. However, Asia is expected to register a higher growth rate during the forecast period owing to huge investment opportunities in this region. The growth of the veterinary vaccines market in the Asia will revolve around China, India, and Thailand.

You can speak To Research Analyst to know more about Report:

http://www.marketsandmarkets.com/speaktoanalyst.asp?id=1233

Major players operating in the veterinary vaccines market are Zoetis (U.S.), Merck Animal Health (U.S.), Merial Inc. (Sanofi) (France), Boehringer Ingelheim (Germany), and Elanco Animal Health (U.S.).

Browse Related Reports:

Veterinary Software Market by Product (Practice Management Software, & Imaging Software), Delivery Model (On-Premise, & Cloud/ Web-based), Practice Type (Small Animal, Mixed, & Large Animal), & End User (Veterinary Clinics, & Laboratory) - Forecast to 2019.

http://www.marketsandmarkets.com/Market-Reports/veterinary-software-market-186264514.html

Veterinary Diagnostics Market by Products (Clinical Chemistry, Hematology Analyzers, Molecular Diagnostics, Immunodiagnostics, Diagnostics Imaging), by Animals (Companion, Food-producing, Dog, Livestock, Poultry, Swine) - Global Forecast to 2018.

http://www.marketsandmarkets.com/Market-Reports/veterinary-diagnostics-market-26017452.html

About MarketsandMarkets:

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html

Contact:Mr. RohanNorth - Dominion Plaza,17304, Preston Road,Suite 800, Dallas, TX 75252Tel: +1-888-600-6441Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/pharmaceuticals